Risk factors for respiratory symptoms and airway obstruction reported in the pre-HAART era might also have changed with HAART.
group, and one case of small bowel obstruction reported as an AE causing discontinuation in the celecoxib 200 mg o.d.
Only 18.8% of never smokers with moderate to severe irreversible airway obstruction reported a previous physician's diagnosis of COPD, emphysema, or chronic bronchitis, compared with 26.0% of ever smokers.
In addition, never smokers with moderate to severe airway obstruction reported more frequent exposure to indoor open fire with coal or coke for cooking (26.9% vs 19.7%), with 22.0% vs 15.3% reporting at least 10 years of exposure, and exposure to organic dusts in the workplace (30.4% vs 23.0%), with 19.3% vs 10.1% reporting at least 10 years of exposure (P <.05, all measures) (Table 2).
The members of this subgroup had, to a lesser degree, given up smoking and seldom reported bad health, compared to those with bronchial obstruction who reported asthma or COPD.
The sweep efficiencies in the region upstream of the obstruction are reported for both the optimized and base cases at different time stages leading to breakthrough.
The rate of subsequent cholangitis after choledochoduodenostomy for benign obstruction is reported 0 to 1.1%, which is extremely lower than the rate after hepaticogastrostomy or drainage using plastic stent [9, 15, 17].
No obstruction was reported and the visual field of view was sufficient to practice surgery.
Even in the early stages of COPD, patients with mild and moderate obstruction are reported to have reduced exercise capacity [ 6].
In subjects with normal bowel function, 113 (97%) had persistent complaints; straining, manual manoeuvres to facilitate bowel movements, feeling of incomplete bowel movements and feeling of anorectal obstruction were reported by 68 (59.5%), 10 (8.0%), 34 (28.6%) and 26 (22.5%) respectively.
